You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 14, 2025

List of Excipients in API olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg

✉ Email this page to a colleague

« Back to Dashboard

Excipients in ANDA-approved (generic) drugs containing olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC	Excipient
REMEDYREPACK INC	olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg	70518-2647	CROSCARMELLOSE SODIUM
REMEDYREPACK INC	olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg	70518-2647	FERRIC OXIDE YELLOW
REMEDYREPACK INC	olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg	70518-2647	LACTOSE MONOHYDRATE
REMEDYREPACK INC	olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg	70518-2647	MAGNESIUM STEARATE
REMEDYREPACK INC	olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg	70518-2647	POLYETHYLENE GLYCOL 400
REMEDYREPACK INC	olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg	70518-2647	POLYVINYL ALCOHOL
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg

Excipient focus: CROSCARMELLOSE SODIUM

olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg drug variants containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
REMEDYREPACK INC	olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg	70518-2647
>Company	>Ingredient	>NDC

olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg drug variants not containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE YELLOW

olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg drug variants containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
REMEDYREPACK INC	olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg	70518-2647
>Company	>Ingredient	>NDC

olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg drug variants not containing FERRIC OXIDE YELLOW

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LACTOSE MONOHYDRATE

olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg drug variants containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
REMEDYREPACK INC	olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg	70518-2647
>Company	>Ingredient	>NDC

olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg drug variants not containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
REMEDYREPACK INC	olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg	70518-2647
>Company	>Ingredient	>NDC

olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYETHYLENE GLYCOL 400

olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg drug variants containing POLYETHYLENE GLYCOL 400

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
REMEDYREPACK INC	olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg	70518-2647
>Company	>Ingredient	>NDC

olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg drug variants not containing POLYETHYLENE GLYCOL 400

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYVINYL ALCOHOL

olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg drug variants containing POLYVINYL ALCOHOL

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
REMEDYREPACK INC	olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg	70518-2647
>Company	>Ingredient	>NDC

olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg drug variants not containing POLYVINYL ALCOHOL

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SILICON DIOXIDE

olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg drug variants containing SILICON DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
REMEDYREPACK INC	olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg	70518-2647
>Company	>Ingredient	>NDC

olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg drug variants not containing SILICON DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: STARCH, CORN

olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg drug variants containing STARCH, CORN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
REMEDYREPACK INC	olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg	70518-2647
>Company	>Ingredient	>NDC

olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg drug variants not containing STARCH, CORN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SUCCINIMIDYL-4-(N-MALEIMIDOMETHYL)CYCLOHEXANE-1-CARBOXYLATE

olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg drug variants containing SUCCINIMIDYL-4-(N-MALEIMIDOMETHYL)CYCLOHEXANE-1-CARBOXYLATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
REMEDYREPACK INC	olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg	70518-2647
>Company	>Ingredient	>NDC

olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg drug variants not containing SUCCINIMIDYL-4-(N-MALEIMIDOMETHYL)CYCLOHEXANE-1-CARBOXYLATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TALC

olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg drug variants containing TALC

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
REMEDYREPACK INC	olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg	70518-2647
>Company	>Ingredient	>NDC

olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg drug variants not containing TALC

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
REMEDYREPACK INC	olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg	70518-2647
>Company	>Ingredient	>NDC

olmesartan medoxomil, amlodipine and hydrochlorothiazide tablet 40/5/25 mg drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.